Thromb Haemost 1963; 10(01): 088-100
DOI: 10.1055/s-0038-1654766
Originalarbeiten — Original Article — Travaux Originaux
Schattauer GmbH

Macrothrombocytic Thrombopathia. Clinical, Coagulation and Hereditary Aspects[*]

Barbara Kańska1
1   Department of Children Diseases and Department of Physiological Chemistry, Medical School, Bialystok, Poland
,
S Niewiarowski2
1   Department of Children Diseases and Department of Physiological Chemistry, Medical School, Bialystok, Poland
,
L Ostrowski3
1   Department of Children Diseases and Department of Physiological Chemistry, Medical School, Bialystok, Poland
,
A Popławski2
1   Department of Children Diseases and Department of Physiological Chemistry, Medical School, Bialystok, Poland
,
J Prokopowicz2
1   Department of Children Diseases and Department of Physiological Chemistry, Medical School, Bialystok, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Summary

Macrothrombocytic thrombopathia (la dystrophie thrombocytaire hémorragipare congénitale) has been diagnosed in two sisters (10 and 12 years old) born of a consanguineous marriage. A short description of the clinical course in both patients is given. Microscopic examinations of stained blood smears revealed an abnormal size of platelets, the diameter of 80 per cent of platelets was greater than 4.3 ì. The platelet count in both children was normal except the period of haemorrhagic crises. The prolongation of bleeding time and defective prothrombin consumption were the only abnormalities found by means of routine coagulation study. Plasma clotting factors were normal. Platelets were lacking factor 1 and 3 but platelets agglutination, viscous metamorphosis and clot retraction were normal. Two forms of macrothrombocytic thrombopathia were ascertained in the patients family (17 members) by means of microscopic and coagulation studies. The first form (homozygous state) is a platelet anomaly associated with defective prothrombin consumption and bleeding tendency. The second one (heterozygous state) consists in platelet anomaly only. The authors suggest that macrothrombocytic thrombopathia is transmitted as an autosomic and incompletely recessive trait, some abnormalities being detected in heterozygotes. It was suggested that the microscopic examination of platelets in stained blood smears offers the possibilty for detection of heterozygotes.

The pathogenesis and the mechanism of hemostatic defect of macrothrombocytic thrombopathia is briefly discussed.

* Aided in part by the grant from the Vlth Department of the Polish Academy of Sciences, Committee for Investigations on Inborn Errors and Foetus Malformations.


1 Postal adress: Klinika Poloznictwa i Chorob Kobiecych, Akademia Medyczna Bialystok.


2 Postal adress: Zaklad Chemii Fizjologicznej, Akademia Medyczna Białystok.


3 Postal adress: Klinika Chirurgiczna, Akademia Medyczna Białystok.


 
  • References

  • 1 Alagille D. personal communication.
  • 2 Bernard J, Soulier JP. Sur une nouvelle variété de dystrophie thrombocytaire hémorragipare congénitale. Sem. Hôp. Paris. 24: 217 1948;
  • 3 Bernard J, Beaumont JL. Charreyron Etude de la fonction thromboplastique des plaquettes dans deux cas de dystrophie thrombocytaire hémorragipare congénitale. Rev. Hémat. 08: 20 1953;
  • 4 Bernard J, Buhot S, Beaumont JL, Larrieu MJ. Sur deux types definis de thrombopathies non thrombopeniques constitutionelles. Le Sang. 02: 117 1954;
  • 5 Bernard J, Caen J, Maroteau P. La dystrophie thrombocytaire hémorragipare congénitale. Rev. Hémat. 12: 222 1957;
  • 6 Braunsteiner H, Pakesch F. Thrombocytoasthenia and thrombocytopathia: old names and new diseases. Blood 11: 965 1956;
  • 7 Borchgreyink CF. Studies on the hemostatic mechanism. Oslo: University Press; 1961
  • 8 Debré R, Bernard J, Soulier JP, Buhot S, Beaumont JL. Lagrue Une nouvelle observation de dystrophie thrombocytaire hémorragipare congénitale. Presse méd. 60: 1271 1952;
  • 9 Duckert F, Flückinger P, Isenschmidt E, Matter M, VogelMeng J. A modification of the thromboplastin generation test. Acta haemat. (Basel) 12: 197 1954;
  • 10 Duke WW. The relationship of blood platelets to haemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of three cases of haemorrhagic disease relieved by transfusion. J. Amer. med. Ass. 55: 1185 1910;
  • 11 Hirsch S, Favre-Gilly J, Dameshek W. Thrombopathie thrombocytopenia. Successful transfusion of blood platelets. Blood 05: 568 1950;
  • 12 Koller F, Loeliger A, Duckert F. Experiments on a new clotting factor. Acta haemat. (Basel) 06: 1 1951;
  • 13 Lee RL, White PD. A clinical study of the coagulation time of blood. Amer. J. med. Sci. 145: 495 1913;
  • 14 Macfarlane RG. A simple method for measuring clot retraction. Lancet I: 1199 1939;
  • 15 Miale JB. Laboratory, Medicine, Haematology. Henry Kimpton; London: 1958
  • 16 Niewiarowski S, Zywicka H, Latałło Z. Coagulation disorders in thrombocythaemia, a study of seven cases. Thrombos. Diathes. haemorrh. (Stuttg) 07: 114 1962;
  • 17 Quick AJ. Hemorrhagic Diseases. Lea and Febiger; Philadelphia: 1954
  • 18 Revol L. A propos de 3 nouveaux cas de “diacyclothrombopathie”. L’épreuve de l’etalement des plaquettes en contraste de phase. Sang. 25: 122 1954;
  • 19 Remde W, Patzelt O, Werner R. Thrombozytose und Thrombozythämie — Symptom oder selbständiges Krankheitsbild?. Blut. 06: 102 1960;
  • 20 Soulier JP, Larrieu MJ. Nouvelle méthode de diagnostic de l’hémophilie; dosage des facteurs antihémophiliques A et B. Sang. 24: 205 1953;
  • 21 Ulutin ON. The qualitative platelet diseases. Henry Ford Hospital International Symposium on Blood Platelets. Little and Brown; Boston: 553 1961
  • 22 Ulutin NO, Karaca M. A study of the pathogenesis of thrombopathia using the platelet osmotic resistance test. Brit. J. Haemat. 05: 302 1959;
  • 23 Wolf P. A modification for routine laboratory use of Stefanini’s method of estimating Factor V activity in human oxalated plasma. J. clin. Path. 06: 34 1953;